• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细小病毒B19感染与自身免疫性疾病。

Parvovirus B19 infection and autoimmune disease.

作者信息

Lehmann Hartwig W, von Landenberg Philipp, Modrow Susanne

机构信息

Klinik für Kinder- und Jugendmedizin, Sächsisches Krankenhaus Hubertusburg, 04779 Wermsdorf, Germany.

出版信息

Autoimmun Rev. 2003 Jun;2(4):218-23. doi: 10.1016/s1568-9972(03)00014-4.

DOI:10.1016/s1568-9972(03)00014-4
PMID:12848949
Abstract

Human parvovirus B19 infections may cause a widespread benign and self-limiting disease in children and adults, known as erythema infectiosum or fifth disease. A variety of further manifestations are associated with the infection such as arthralgias, arthritis, leukopenia and thrombocytopenia, anemia and vasculitis, spontaneous abortion and hydrops fetalis in pregnant women. Both in children and adults parvovirus B19 infections have been frequently implicated as a cause or trigger of various forms of autoimmune diseases affecting joints, connective tissue and large and small vessels. In addition, autoimmune neutropenia, thrombocytopenia and hemolytic anemia are known as sequelae of B19 infection. The molecular basis of the autoimmune phenomena and resultant pathogenesis is unclear. The involvement of molecular mimicry between cellular and viral proteins, the induction of enhanced cytokine production via the viral transactivator protein NS1 and the phospholipase A2-like activity of the capsid protein VP1 may contribute to the induction of autoimmune reactions. All the known data and the potential mechanisms involved in the pathogenesis will be discussed in this review.

摘要

人细小病毒B19感染可在儿童和成人中引起一种广泛的良性自限性疾病,称为传染性红斑或第五病。该感染还伴有多种其他表现,如关节痛、关节炎、白细胞减少、血小板减少、贫血和血管炎,孕妇可出现自然流产和胎儿水肿。在儿童和成人中,细小病毒B19感染常被认为是影响关节、结缔组织以及大小血管的各种自身免疫性疾病的病因或触发因素。此外,自身免疫性中性粒细胞减少、血小板减少和溶血性贫血是B19感染的后遗症。自身免疫现象及由此产生的发病机制的分子基础尚不清楚。细胞蛋白与病毒蛋白之间的分子模拟、病毒反式激活蛋白NS1诱导细胞因子产生增加以及衣壳蛋白VP1的磷脂酶A2样活性可能都有助于自身免疫反应的诱导。本综述将讨论所有已知数据及发病机制中涉及的潜在机制。

相似文献

1
Parvovirus B19 infection and autoimmune disease.细小病毒B19感染与自身免疫性疾病。
Autoimmun Rev. 2003 Jun;2(4):218-23. doi: 10.1016/s1568-9972(03)00014-4.
2
Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard?细小病毒B19:是扩张型心肌病的病原体还是人类心肌的无害过客?
Ernst Schering Res Found Workshop. 2006(55):63-82. doi: 10.1007/3-540-30822-9_5.
3
Human parvovirus B19 infection and antiphospholipid antibodies.人细小病毒B19感染与抗磷脂抗体
Autoimmun Rev. 2007 Apr;6(5):278-85. doi: 10.1016/j.autrev.2006.09.006. Epub 2006 Oct 13.
4
Human parvovirus B19 infection and autoimmunity.人细小病毒B19感染与自身免疫
Autoimmun Rev. 2008 Dec;8(2):116-20. doi: 10.1016/j.autrev.2008.07.005.
5
Antibody responses in parvovirus B19 infected patients.细小病毒B19感染患者的抗体反应。
Pathol Biol (Paris). 2002 Jun;50(5):326-31. doi: 10.1016/s0369-8114(02)00302-4.
6
Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?抗磷脂抗体是对感染产生有效免疫反应的必要条件吗?
Ann N Y Acad Sci. 2007 Jun;1108:578-83. doi: 10.1196/annals.1422.060.
7
Clinical aspects of parvovirus B19 infection.细小病毒B19感染的临床方面
J Intern Med. 2006 Oct;260(4):285-304. doi: 10.1111/j.1365-2796.2006.01697.x.
8
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.细小病毒B19在自身免疫及自身免疫性疾病发病机制中的作用。
J Clin Pathol. 2016 Apr;69(4):279-91. doi: 10.1136/jclinpath-2015-203455. Epub 2015 Dec 7.
9
Impaired gamma interferon responses against parvovirus B19 by recently infected children.近期感染儿童针对细小病毒B19的γ干扰素反应受损。
J Virol. 2000 Nov;74(21):9903-10. doi: 10.1128/jvi.74.21.9903-9910.2000.
10
Erythema Infectiosum: A Narrative Review.传染性红斑:一篇综述
Curr Pediatr Rev. 2024;20(4):462-471. doi: 10.2174/1573396320666230428104619.

引用本文的文献

1
Acute Hemolytic Anemia and Immune Thrombocytopenia: A Rare Case of Parvovirus B19-Induced Evans Syndrome.急性溶血性贫血和免疫性血小板减少症:1例罕见的细小病毒B19感染所致伊文氏综合征
Cureus. 2025 Jul 27;17(7):e88845. doi: 10.7759/cureus.88845. eCollection 2025 Jul.
2
Genotypic Characterization of Human Parvovirus B19 Circulating in the 2024 Outbreak in Tuscany, Italy.意大利托斯卡纳地区2024年疫情中流行的人细小病毒B19的基因特征分析。
Pathogens. 2025 Jan 28;14(2):121. doi: 10.3390/pathogens14020121.
3
Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
髓鞘-微生物相互作用的生物信息学分析表明,在多发性硬化症的发病机制中存在多种分子模拟类型。
PLoS One. 2024 Dec 30;19(12):e0308817. doi: 10.1371/journal.pone.0308817. eCollection 2024.
4
Immune Cell Profiles of Patients with Sickle Cell Disease during Parvovirus B19-Induced Transient Red Cell Aplasia.细小病毒B19诱导的短暂红细胞再生障碍期间镰状细胞病患者的免疫细胞谱
Vaccines (Basel). 2024 Aug 29;12(9):984. doi: 10.3390/vaccines12090984.
5
Parvovirus B19 in Rheumatic Diseases.风湿性疾病中的细小病毒B19
Microorganisms. 2024 Aug 19;12(8):1708. doi: 10.3390/microorganisms12081708.
6
Case series: Congenital enterovirus infection-associated haemophagocytic lymphohistiocytosis and subsequent neutropaenia.病例系列:先天性肠道病毒感染相关噬血细胞性淋巴组织细胞增生症及随后的中性粒细胞减少症
EJHaem. 2024 Jun 18;5(4):784-788. doi: 10.1002/jha2.931. eCollection 2024 Aug.
7
Reconstructing Prehistoric Viral Genomes from Neanderthal Sequencing Data.从尼安德特人测序数据中重建史前病毒基因组。
Viruses. 2024 May 27;16(6):856. doi: 10.3390/v16060856.
8
Celastrol attenuates human parvovirus B19 NS1‑induced NLRP3 inflammasome activation in macrophages.毛地黄皂苷抑制人细小病毒 B19 NS1 诱导的巨噬细胞中的 NLRP3 炎性体激活。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13080. Epub 2023 Sep 1.
9
Medical Applications of Molecular Biotechnologies in the Context of Hashimoto's Thyroiditis.分子生物技术在桥本甲状腺炎背景下的医学应用
Diagnostics (Basel). 2023 Jun 19;13(12):2114. doi: 10.3390/diagnostics13122114.
10
Investigation of human parvovirus B19 prevalence in a large healthy umbilical cord blood donors.大型健康脐带血捐献者中人类细小病毒B19感染率的调查。
Iran J Microbiol. 2022 Feb;14(1):119-124. doi: 10.18502/ijm.v14i1.8813.